A Department of Veterans Affairs (VA) database study shows that new drug regimens for hepatitis C have resulted in “remarkably high” cure rates among patients in VA's national health care system. Of the more than 17,000 Veterans in the study, all chronically infected with the hepatitis C virus at baseline, 75 percent to 93 percent had no detectable levels of the disease in their blood for 12 or more weeks after the end of treatment. An abstract of the study is available in the September 2016 issue of the journal Gastroenterology. For more information on VA care for hepatitis C, visit the VA Viral Hepatitis website and the VA Hepatitsis C webpage.
For more on veteran benefits, visit the Military.com Benefits Center.
